148 related articles for article (PubMed ID: 12406196)
1. Diminished immunopathology in Schistosoma mansoni infection following intranasal administration of cholera toxin B-immunodominant peptide conjugate correlates with enhanced transforming growth factor-beta production by CD4 T cells.
Hernandez HJ; Rutitzky LI; Lebens M; Holmgren J; Stadecker MJ
Parasite Immunol; 2002 Aug; 24(8):423-7. PubMed ID: 12406196
[TBL] [Abstract][Full Text] [Related]
2. Nasal administration of Schistosoma mansoni egg antigen-cholera B subunit conjugate suppresses hepatic granuloma formation and reduces mortality in S. mansoni-infected mice.
Sun JB; Stadecker MJ; Mielcarek N; Lakew M; Li BL; Hernandez HJ; Czerkinsky C; Holmgren J
Scand J Immunol; 2001 Nov; 54(5):440-7. PubMed ID: 11696194
[TBL] [Abstract][Full Text] [Related]
3. Expansion of CD4 T cells expressing a highly restricted TCR structure specific for a single parasite epitope correlates with high pathology in murine schistosomiasis.
Finger E; Brodeur PH; Hernandez HJ; Stadecker MJ
Eur J Immunol; 2005 Sep; 35(9):2659-69. PubMed ID: 16106372
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
[TBL] [Abstract][Full Text] [Related]
5. Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni.
Chen Y; Boros DL
J Immunol; 1998 Jun; 160(11):5420-7. PubMed ID: 9605143
[TBL] [Abstract][Full Text] [Related]
6. Nasal administration of Schistosoma mansoni egg antigens-cholera toxin B subunit conjugate to infected mice reduces immunopathology and mortality.
Sun JB; Li BL; Lakew M; Grzych JM; Capron A; Czerkinsky C; Holmgren J
Adv Exp Med Biol; 2001; 495():305-9. PubMed ID: 11774583
[No Abstract] [Full Text] [Related]
7. Apoptosis by neglect of CD4+ Th cells in granulomas: a novel effector mechanism involved in the control of egg-induced immunopathology in murine schistosomiasis.
Rutitzky LI; Mirkin GA; Stadecker MJ
J Immunol; 2003 Aug; 171(4):1859-67. PubMed ID: 12902487
[TBL] [Abstract][Full Text] [Related]
8. The identification and characterization of new immunogenic egg components: implications for evaluation and control of the immunopathogenic T cell response in schistosomiasis.
Stadecker MJ; Hernandez HJ; Asahi H
Mem Inst Oswaldo Cruz; 2001; 96 Suppl():29-33. PubMed ID: 11586423
[TBL] [Abstract][Full Text] [Related]
9. The immune response and immunopathology in infection with Schistosoma mansoni: a key role of major egg antigen Sm-p40.
Stadecker MJ; Hernandez HJ
Parasite Immunol; 1998 May; 20(5):217-21. PubMed ID: 9651922
[TBL] [Abstract][Full Text] [Related]
10. Schistosomal granuloma modulation. I. Schistosoma mansoni worm antigens CAA and CCA prime egg-antigen-induced hepatic granuloma formation.
Jacobs W; van Dam G; Bogers J; Deelder A; Van Marck E
Parasitol Res; 1999 Jan; 85(1):7-13. PubMed ID: 9950221
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni: genetic restriction and cytokine profile of the CD4 + T helper cell response to dominant epitope peptide of major egg antigen Sm-p40.
Hernandez HJ; Edson CM; Harn DA; Ianelli CJ; Stadecker MJ
Exp Parasitol; 1998 Sep; 90(1):122-30. PubMed ID: 9709038
[TBL] [Abstract][Full Text] [Related]
12. Rational selection of immunodominant and preserved epitope Sm043300e from Schistosoma mansoni and design of a chimeric molecule for biotechnological purposes.
de Souza C; Lopes MD; De Oliveira FM; Passos MJF; Ferreira LCG; Faria BF; Villar JAFP; Junior MC; Taranto AG; Dos Santos LL; Fonseca CT; de Oliveira Lopes D
Mol Immunol; 2018 Jan; 93():133-143. PubMed ID: 29175593
[TBL] [Abstract][Full Text] [Related]
13. Immunoregulatory potential of exogenous Schistosoma mansoni soluble egg antigen in a model of experimental schistosomiasis--I. Regulation of granuloma formation in vivo.
Botros SS; Hassanein HI; Hassan SI; Akl MM; Sakr SS; Shaker ZA; Hafez GL; el Ghorab NM; Dean DA
Int J Immunopharmacol; 1995 Apr; 17(4):291-302. PubMed ID: 7672880
[TBL] [Abstract][Full Text] [Related]
14. Immunological cross reactivity between Schistosoma mansoni and cholera toxin.
Akhiani AA; Nilsson LA; Ouchterlony O
Parasite Immunol; 1997 Aug; 19(8):355-61. PubMed ID: 9292894
[TBL] [Abstract][Full Text] [Related]
15. Granulomatous hypersensitivity to Schistosoma mansoni egg antigens in human schistosomiasis. I. Granuloma formation and modulation around polyacrylamide antigen-conjugated beads.
Doughty BL; Goes AM; Parra JC; Rocha RS; Katz N; Colley DG; Gazzinelli G
Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():47-54. PubMed ID: 3151115
[TBL] [Abstract][Full Text] [Related]
16. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.
Hernandez HJ; Wang Y; Stadecker MJ
J Immunol; 1997 May; 158(10):4832-7. PubMed ID: 9144498
[TBL] [Abstract][Full Text] [Related]
17. T-bet protects against exacerbation of schistosome egg-induced immunopathology by regulating Th17-mediated inflammation.
Rutitzky LI; Smith PM; Stadecker MJ
Eur J Immunol; 2009 Sep; 39(9):2470-81. PubMed ID: 19714576
[TBL] [Abstract][Full Text] [Related]
18. Murine immune responses to a novel schistosome egg antigen, SmEP25.
Williams DL; Asahi H; Oke TT; Lopes da Rosa J; Stadecker MJ
Int J Parasitol; 2005 Jul; 35(8):875-82. PubMed ID: 15970293
[TBL] [Abstract][Full Text] [Related]
19. Splenic and granuloma T-lymphocyte responses to fractionated soluble egg antigens of Schistosoma mansoni-infected mice.
Lukacs NW; Boros DL
Infect Immun; 1991 Mar; 59(3):941-8. PubMed ID: 1900066
[TBL] [Abstract][Full Text] [Related]
20. Polarization of the immune response to the single immunodominant epitope of p38, a major Schistosoma mansoni egg antigen, generates Th1- or Th2-type cytokines and granulomas.
Chen Y; Boros DL
Infect Immun; 1999 Sep; 67(9):4570-7. PubMed ID: 10456902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
